Robert Sussman

4.9k total citations · 1 hit paper
20 papers, 3.3k citations indexed

About

Robert Sussman is a scholar working on Pulmonary and Respiratory Medicine, Occupational Therapy and Chemical Health and Safety. According to data from OpenAlex, Robert Sussman has authored 20 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Occupational Therapy and 4 papers in Chemical Health and Safety. Recurrent topics in Robert Sussman's work include Inhalation and Respiratory Drug Delivery (6 papers), Safe Handling of Antineoplastic Drugs (5 papers) and Chemical Safety and Risk Management (4 papers). Robert Sussman is often cited by papers focused on Inhalation and Respiratory Drug Delivery (6 papers), Safe Handling of Antineoplastic Drugs (5 papers) and Chemical Safety and Risk Management (4 papers). Robert Sussman collaborates with scholars based in United States, Switzerland and Australia. Robert Sussman's co-authors include Elizabeth A. Fagan, Williamson Z. Bradford, Ian Glaspole, Marilyn K. Glassberg, Eduard Gorina, Steven D. Nathan, Jeffrey J. Swigris, David Kardatzke, Lisa Lancaster and David J. Lederer and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Robert Sussman

20 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

2014 2.6k citations Talmadge E. King, Williamson Z. Bradford et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Sussman United States	12	2.9k	780	309	296	243	20	3.3k
Sakae Homma Japan	33	2.6k 0.9×	848 1.1×	560 1.8×	331 1.1×	361 1.5×	250	3.5k
Paolo Cameli Italy	27	1.4k 0.5×	719 0.9×	241 0.8×	145 0.5×	281 1.2×	162	2.3k
Francesco Bonella Germany	41	3.9k 1.3×	1.3k 1.7×	576 1.9×	422 1.4×	341 1.4×	212	4.5k
D.M. Hansell United Kingdom	24	1.8k 0.6×	589 0.8×	355 1.1×	146 0.5×	68 0.3×	47	2.1k
Joo Hun Park South Korea	22	1.5k 0.5×	586 0.8×	310 1.0×	121 0.4×	392 1.6×	85	2.1k
Eli Gabbay Australia	27	1.8k 0.6×	336 0.4×	362 1.2×	216 0.7×	121 0.5×	84	2.5k
Huaping Dai China	28	1.4k 0.5×	376 0.5×	321 1.0×	92 0.3×	594 2.4×	144	2.4k
Carlo Albera Italy	16	3.9k 1.4×	1.4k 1.8×	506 1.6×	545 1.8×	212 0.9×	48	4.2k
Thomas A. Sporn United States	27	2.0k 0.7×	315 0.4×	203 0.7×	220 0.7×	337 1.4×	88	2.7k
T Ashcroft United Kingdom	22	2.2k 0.8×	301 0.4×	409 1.3×	202 0.7×	453 1.9×	49	3.3k

Countries citing papers authored by Robert Sussman

Since Specialization

Citations

This map shows the geographic impact of Robert Sussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Sussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Sussman more than expected).

Fields of papers citing papers by Robert Sussman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Sussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Sussman. The network helps show where Robert Sussman may publish in the future.

Co-authorship network of co-authors of Robert Sussman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Sussman. A scholar is included among the top collaborators of Robert Sussman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Sussman. Robert Sussman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levine, Alexandra M., et al.. (2021). AN INTERESTING CASE OF E-CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY. CHEST Journal. 160(4). A1680–A1680. 1 indexed citations

Flaherty, Kevin R., Charlene D. Fell, John T. Huggins, et al.. (2018). Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis. European Respiratory Journal. 52(2). 1800230–1800230. 99 indexed citations

Sussman, Robert, et al.. (2016). A harmonization effort for acceptable daily exposure derivation – Considerations for application of adjustment factors. Regulatory Toxicology and Pharmacology. 79. S57–S66. 35 indexed citations

Hayes, Eileen P., Robert A. Jolly, Ellen C. Faria, et al.. (2016). A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing – Operational considerations. Regulatory Toxicology and Pharmacology. 79. S39–S47. 21 indexed citations

Olson, Michael J., Ellen C. Faria, Eileen P. Hayes, et al.. (2016). Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning. Regulatory Toxicology and Pharmacology. 79. S19–S27. 10 indexed citations

Sussman, Robert, et al.. (2016). Identifying and assessing highly hazardous drugs within quality risk management programs. Regulatory Toxicology and Pharmacology. 79. S11–S18. 13 indexed citations

King, Talmadge E., Williamson Z. Bradford, Elizabeth A. Fagan, et al.. (2014). A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. 370(22). 2083–2092. 2606 indexed citations breakdown →

King, Talmadge E., Williamson Z. Bradford, Elizabeth Fagan, et al.. (2014). Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP). 44. 4629. 1 indexed citations

Sargent, Edward V., Ellen C. Faria, Thomas D. Pfister, & Robert Sussman. (2013). Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products. Regulatory Toxicology and Pharmacology. 65(2). 242–250. 19 indexed citations

10.

Sussman, Robert, et al.. (2011). Developing Acceptable Surface Limits for Occupational Exposure to Pharmaceutical Substances. Journal of ASTM International. 8(8). 1–6. 8 indexed citations

11.

Sussman, Robert. (2007). Part I: Identifying chronic obstructive pulmonary disease in patients with respiratory symptoms. Current Medical Research and Opinion. 23(sup3). S5–S12. 3 indexed citations

12.

Johnson, Fred L., et al.. (2004). Improved Diagnostic Sensitivity for Lung Cancer Using an Automated Quantitative Cytology System and Uridine 5'-Triphosphate-Induced Sputum Specimens. CHEST Journal. 125(5). 157S–158S. 7 indexed citations

13.

Cohen, Beverly S., Robert Sussman, & Morton Lippmann. (1993). Factors affecting distribution of airflow in a human tracheobronchial cast. Respiration Physiology. 93(3). 261–278. 21 indexed citations

14.

Leung, Hon‐Wing, et al.. (1992). Scientific and practical considerations for the development of occupational exposure limits (OELs) for chemical substances. Regulatory Toxicology and Pharmacology. 15(3). 291–306. 45 indexed citations

15.

Sussman, Robert, Beverly S. Cohen, & Morton Lippmann. (1991). Asbestos Fiber Deposition in a Human Tracheobronchial Cast. Ii. Empirical Model. Inhalation Toxicology. 3(2). 161–179. 24 indexed citations

16.

Sussman, Robert, Beverly S. Cohen, & Morton Lippmann. (1991). Asbestos Fiber Deposition in a Human Tracheobronchial Cast. I. Experimental. Inhalation Toxicology. 3(2). 145–160. 49 indexed citations

17.

Cohen, Beverly S., Robert Sussman, & Morton Lippmann. (1990). Ultrafine Particle Deposition in a Human Tracheobronchial Cast. Aerosol Science and Technology. 12(4). 1082–1091. 120 indexed citations

18.

Naidich, David P., et al.. (1988). Solitary Pulmonary Nodules. CHEST Journal. 93(3). 595–598. 187 indexed citations

19.

Sussman, Robert, Jeffrey Gearhart, & Morton Lippmann. (1985). A Variable Feed Rate Mechanism for Fluidized Bed Asbestos Generators. American Industrial Hygiene Association Journal. 46(1). 24–27. 1 indexed citations

20.

Jaeger, Rudolph J., et al.. (1983). Repeated pulmonary function evaluation following bleomycin treatment. Journal of Toxicology and Environmental Health. 11(3). 415–423. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact